Topics

Opinion: The FDA has an opportunity to ease regulatory uncertainty by proposing a framework that guides how sponsors can use AI tools within drug development programs. https://buff.ly/2JXKjr6 

21:00 EST 7 Nov 2019 | STAT

Opinion: The FDA has an opportunity to ease regulatory uncertainty by proposing a framework that guides how sponsors can use AI tools within drug development programs. https://buff.ly/2JXKjr6 

Original Article: Opinion: The FDA has an opportunity to ease regulatory uncertainty by proposing a framework that guides how sponsors can use AI tools within drug development programs. https://buff.ly/2JXKjr6 

NEXT ARTICLE

More From BioPortfolio on "Opinion: The FDA has an opportunity to ease regulatory uncertainty by proposing a framework that guides how sponsors can use AI tools within drug development programs. https://buff.ly/2JXKjr6 "

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...